FundedIQ

Recently Funded Series A Biotechnology Startups

Updated Sep 2026

There are 571 funded Series A Biotechnology startups in the FundedIQ database, each with its funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Series A Biotechnology startup funding landscape, along with the 100 most recently funded Series A Biotechnology startups.

Cambridge and San Diego hold the deepest concentrations of these companies. Series A Biotechnology startups closed 202 funding rounds over the last 24 months, 116 of them in the last 12 months, and raised $8.0B in disclosed capital. The median disclosed round is $20M, with the middle half of rounds falling between $11M and $50M.

Biotechnology activity centers in the United States, though significant presence exists across the United Kingdom, France, Germany, and Switzerland. This geographic spread means the segment spans several different regulatory jurisdictions. Capital from firms like Eli Lilly and Matrix Partners China supports a wide distribution of sites rather than a single urban center.

Series A Biotechnology funded startup statistics

Funded Series A Biotechnology startups
571
tracked in the database
Funding rounds, last 12 months
116
202 over 24 months
Disclosed capital raised, 24 months
$8.0B
189 of 202 rounds disclosed an amount
Median round size
$20M
middle half $11M to $50M

Most recent funding round on record: Sep 2026. Investors appearing most often across Biotechnology funding rounds: Eli Lilly, RA Capital Management, Gaingels, Matrix Partners China, Michael J. Fox Foundation.

100 most recently funded Series A Biotechnology startups

100 of 571

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

A
Liège, Belgium · Biotechnology
Amyl therapeutics is a preclinical-stage biotechnology company pioneering a breakthrough approach to treating…
Series A ·
$9.6M
E
Kirkland, United States · Biotechnology
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Series A ·
$35M
A
Lausanne, Switzerland · Biotechnology
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Series A ·
$40M
P
Salt Lake City, United States · Biotechnology
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Series A ·
$6.3M
O
Lexington, United States · Biotechnology
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
Series A ·
$7.0M
R
Needham, United States · Biotechnology
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Series A ·
$10M
D
Boston, United States · Biotechnology
Dash Bio is a cutting-edge platform that employs AI, robotics, and fully integrated software to revolutionize…
Series A ·
$30M
P
Shenzhen, China · Biotechnology
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Series A ·
$15M
Y
Tianjin, China · Biotechnology
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
Series A ·
$15M
N
Weifang, China · Biotechnology
NewLine researches phage feed additives to prevent livestock infections.
Series A ·
$15M
B
Issoire, France · Biotechnology
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
Series A ·
$13M
A
Daejeon, South Korea · Biotechnology
ArcGen Bioscience is a biopharmaceutical development company
Series A ·
$6.7M
A
London, United Kingdom · Biotechnology
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Series A ·
$34M
B
Boston, United States · Biotechnology
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune…
Series A ·
$126M
R
London, United Kingdom · Biotechnology
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
Series A ·
$113M
A
Boston, United States · Biotechnology
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of…
Series A ·
$13M
R
Carlsbad, United States · Biotechnology
Rapalogix Health is a biotechnology company focused on developing longevity-based solutions for skin health…
Series A ·
$20M
A
Ibaraki, Japan · Biotechnology
Arrowsmith is committed to unlocking the full potential of bacteriophages to revolutionize the treatment of…
Series A ·
$6.5M
S
Chicago, United States · Biotechnology
Syntax Bio is a synthetic biology and biotechnology company that develops a CRISPR-based cell programming…
Series A ·
$14M
V
Seattle, United States · Biotechnology
Vedana Therapeutics is a Seattle biotechnology company developing next-generation antibody therapies for…
Series A ·
$46M
A
Aton Health
Kansas City, United States · Biotechnology
Aton Health connects biotech study sponsors with a network of highly engaged clinicians and unprecedented…
Series A ·
Undisclosed
D
Tokyo, Japan · Biotechnology
Dioseve is providing novel possibilities for all life.
Series A ·
$6.2M
F
Brooklyn, United States · Biotechnology
Fesarius Therapeutics is a biotechnology company that intends to develop and sell modified skin replacement…
Series A ·
$20M
M
Aliso Viejo, United States · Biotechnology
Mammogen is a female-led precision health company that is committed to dramatically improving the detection,…
Series A ·
$30M
T
Dorchester, United States · Biotechnology
Tavo Biotherapeutics is a biotech company that develops injection therapies for eye diseases.
Series A ·
$17M
I
London, United Kingdom · Biotechnology
IMU is a discovery engine mapping the immune system to advance precision medicine.
Series A ·
$38M
O
Altrincham, United Kingdom · Biotechnology
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
Series A ·
$33M
E
Los Angeles, United States · Biotechnology
Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe…
Series A ·
Undisclosed
P
Berlin, Germany · Biotechnology
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
Series A ·
$8.1M
S
Dallas, United States · Biotechnology
A pipeline of secretome products is being developed by secretome Therapeutics to treat disorders brought on…
Series A ·
$30M
W
New York, United States · Biotechnology
Optimizing cell therapy with spatial biology
Series A ·
$20M
C
San Diego, United States · Biotechnology
cAMPfield Therapeutics is a biotechnology company that specializes on exploration and development activities…
Series A ·
$180M
O
Houston, United States · Biotechnology
Oorja Bio is is a clinical-stage biotechnology company focused on developing therapies for idiopathic…
Series A ·
$30M
S
Tel Aviv, Israel · Biotechnology
SuperMeat is an Israeli bio-tech and food-tech organization, fostering an innovation to make clean meat from…
Series A ·
$6.0M
C
Altrincham, United Kingdom · Biotechnology
Cytospire Therapeutics is bringing forward a portfolio of next generation immune cell engagers.
Series A ·
$83M
K
Monmouth Junction, United States · Biotechnology
Kanvas Biosciences has created advanced imaging technology for identifying microbes, offering unparalleled…
Series A ·
$48M
P
Palo Alto, United States · Biotechnology
Pumpkinseed allows for high-speed readings of biological bits.
Series A ·
$20M
A
Cambridge, United States · Biotechnology
Series A ·
$55M
A
Laguna Hills, United States · Biotechnology
Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in…
Series A ·
$35M
M
Munich, Germany · Biotechnology
Mbiomics is a company in the field of biotechnology.
Series A ·
$12M
C
Heverlee, Belgium · Biotechnology
Coultreon Biopharma is developing best-in-class therapeutics that target clinically validated pathways in…
Series A ·
$125M
F
New York, United States · Biotechnology
Fathom Therapeutics, previously known as Atommap, is a biotechnology company focused on designing therapeutic…
Series A ·
$47M
G
Tokyo, Japan · Biotechnology
Gel-Coat Biomaterials is a biotechnology company that develops innovative bio-based materials and new medical…
Series A ·
$1.3M
M
Nara, Japan · Biotechnology
Molmir is a biotech company that conducts research and develops treatments for intractable diseases based on…
Series A ·
$1.9M
T
Framingham, United States · Biotechnology
Tortugas Neuroscience is a neurology-focused biotech company dedicated to developing effective medicines that…
Series A ·
$106M
S
Shinjuku, Japan · Biotechnology
SONIRE Therapeutics Inc. (SONIRE) is working on a next-generation high-intensity focused ultrasound (HIFU)…
Series A ·
$18M
N
Louvain-la-neuve, Belgium · Biotechnology
neuroClues provides easy-to-use eye-tracking environment to help practitioners instantaneously quantify their…
Series A ·
$12M
S
Cambridge, United States · Biotechnology
Stipple Bio is a biotech company that focuses on advancing cellular profiling and target discovery using…
Series A ·
$100M
G
Paris, France · Biotechnology
Natural products have contributed more than 500 molecules to pharmaceuticals. However, conventional methods…
Series A ·
$23M
C
Orange, Australia · Biotechnology
Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…
Series A ·
$13M
G
New York, United States · Biotechnology
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of…
Series A ·
$60M
I
Cambridge, United Kingdom · Biotechnology
Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic…
Series A ·
$87M
O
Biotechnology
Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for…
Series A ·
$21M
C
San Francisco, United States · Biotechnology
Carecubes develops medical-grade isolation technology that helps caregivers respond to pandemics in a calm…
Series A ·
$6.5M
B
Edinburgh, United Kingdom · Biotechnology
Bioliberty is a young healthcare technology company that focuses on creating innovative rehabilitation…
Series A ·
$8.3M
C
San Diego, United States · Biotechnology
Condor Software develops financial management software for clinical trials in the biopharmaceutical sector.…
Series A ·
$24M
K
Schönefeld, Germany · Biotechnology
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
Series A ·
$12M
R
London, United Kingdom · Biotechnology
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
Series A ·
$78M
V
Cambridge, United States · Biotechnology
Vima Therapeutics operates as a biotechnology company.Vima Therapeutics creates a new era in treatments for…
Series A ·
$40M
M
Biotechnology
MAX BioPharma is a California-based biotechnology firm developing novel small molecule lipids, referred to as…
Series A ·
$13M
T
South San Francisco, United States · Biotechnology
Tacit Therapeutics created RNA-targeting treatments for devastating diseases. By repurposing pre-existing…
Series A ·
$19M
C
Norderstedt, Germany · Biotechnology
Cellbox Solutions is a recently established technology firm that specializes in creative logistics solutions…
Series A ·
$4.1M
P
New York, United States · Biotechnology
Prolium is a biotechnology company, which specializes in providing breakthrough therapies to the patients…
Series A ·
$50M
A
Menlo Park, United States · Biotechnology
Abram’s is a novel diagnostic platform for diagnosis and characterization of coagulation-related disorders,…
Series A ·
$12M
S
Raleigh, United States · Biotechnology
Slate Medicines is a biotechnology company that develops therapeutics that target Pituitary Adenylate…
Series A ·
$130M
S
Ramat Hasharon, Israel · Biotechnology
Starget Pharma is a clinical stage company developing a pipeline of radioligand therapy programs generated…
Series A ·
$18M
E
Los Angeles, United States · Biotechnology
Evergreen is a game-changing solution to the environmental, health, and animal welfare challenges posed by…
Series A ·
$6.0M
T
Boston, United States · Biotechnology
Third Arc Bio is a biotechnology company that is working on the creation of versatile antibodies for diseases…
Series A ·
$52M
K
Haverhill, United Kingdom · Biotechnology
KluraLabs is a manufacturing company that develops products using nanotechnology to inactivate viruses and…
Series A ·
$11M
P
Houston, United States · Biotechnology
Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered…
Series A ·
$17M
O
Copenhagen, Denmark · Biotechnology
Pioneering new sustainable bio-based ingredients
Series A ·
$5.9M
T
Boulder, United States · Biotechnology
Think Bioscience is changing the way synthetic biology is approached, by using living systems to help create…
Series A ·
$55M
M
Christchurch, New Zealand · Biotechnology
Mars Bioimaging Ltd (MBI) was formed in 2007 to commercialise the ground-breaking MARS imaging system for its…
Series A ·
$15M
B
Recoleta, Argentina · Biotechnology
BIOMAKERS is a biotechnology research company that offers molecular testing and genetic diagnosis for patient…
Series A ·
$8.0M
E
London, United Kingdom · Biotechnology
Engitix is using its proprietary human organ decellularisation technology to develop tissue engineered…
Series A ·
$25M
C
Boston, United States · Biotechnology
Corsera Health develops preventive RNA interference medicines focused on reducing cardiovascular disease risk…
Series A ·
$80M
L
Galway, Ireland · Biotechnology
Luminate Medical develops a medical device designed to prevent hair loss during chemotherapy. Luminate…
Series A ·
$21M
R
Denver, United States · Biotechnology
RheumaGen is a gene-editing technology that is working on developing treatments for curing rheumatoid…
Series A ·
Undisclosed
A
South San Francisco, United States · Biotechnology
Addition Therapeutics focuses on developing RNA-only therapeutics using its proprietary PRINT technology.…
Series A ·
$100M
F
Adelaide, Australia · Biotechnology
A patented magnetic probe from the University of South Australia and iron magnetic nanoparticle technology…
Series A ·
$6.0M
F
Copenhagen, Denmark · Biotechnology
Fida Biosystems is a technology that provides the detection and characterization of proteins and…
Series A ·
$5.9M
L
San Francisco, United States · Biotechnology
Link Cell Therapies develops engineered cell therapy technologies intended to create targeted CAR T-based…
Series A ·
$60M
N
Cairo, Egypt · Biotechnology
Cutting edge research is available exclusively to those with high tech equipment in their labs. Nawah is a…
Series A ·
$23M
M
New York, United States · Biotechnology
MEND is a company focused on life sciences, determined to assist individuals in achieving better health…
Series A ·
$20M
P
San Francisco, United States · Biotechnology
ProLynx is a biotechnology company that develops proprietary drug-delivery technologies designed to extend…
Series A ·
$70M
A
Boston, United States · Biotechnology
Allonnia is a waste management company specializing in bioremediation. They develop advanced biotechnology…
Series A ·
$20M
A
Lyon, France · Biotechnology
Axoltis pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
Series A ·
$21M
C
Albuquerque, United States · Biotechnology
Circular Genomics, headquartered in Albuquerque, New Mexico, is a biotech and genomics firm that focuses on…
Series A ·
$15M
M
Montréal, Canada · Biotechnology
Morphocell Technologies is a regenerative medicine company focused on the development and commercialization…
Series A ·
$10M
J
JGene Biotechnology
Shenzhen, China · Biotechnology
JGene Biotechnology is a biotechnology company engaged in the research of gene and cell therapies for tumor…
Series A ·
Undisclosed
I
Bengaluru, India · Biotechnology
ImmunitoAI is a life sciences (biotech) platform that leverages AI to revolutionize antibody discovery &…
Series A ·
$6.1M
U
U-Sweet Biotechnology
Changzhou, China · Biotechnology
U-Sweet Biotechnology focuses on the innovative application of biotechnology in the food industry.
Series A ·
Undisclosed
B
Boston, United States · Biotechnology
Bambusa Therapeutics is a biotechnology company that specializes in the development of bispecific antibodies.
Series A ·
Undisclosed
I
Ness Ziona, Israel · Biotechnology
IBI-Ag is a biotechnology firm that specializes in creating innovative bioinsecticides. Their primary focus…
Series A ·
$3.9M
T
Taihao Biotechnology
Beijing, China · Biotechnology
Taihao Biotechnology specializes in research, development, production, and sales of rapid testing equipment…
Series A ·
Undisclosed
R
Melbourne, Australia · Biotechnology
RAGE Biotech is a biotechnology industry.
Series A ·
$19M
O
San Diego, United States · Biotechnology
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment…
Series A ·
$25M
P
Cambridge, United Kingdom · Biotechnology
PACT creates stylish products made in harmony with the environment by developing innovative, eco-friendly…
Series A ·
$21M
C
Mountain View, United States · Biotechnology
Curve Biosciences specializes in precision medicine for chronic diseases, led by a team of experts like…
Series A ·
$40M
E
Dijon, France · Biotechnology
Exeliom is a biopharmaceutical company in the clinical stage that focuses on using commensal bacteria as…
Series A ·
$3.3M

471 more funded startups

571 startups · 100 visible Unlock with FundedIQ

This page shows the 100 most recent rounds (back to Oct 2025). The full 571-company history for this listing opens on a FundedIQ plan.

Company
Location
Round
Amount

Unlock all 571 companies in this listing: full funding history, investors, and founders.

Start 14-day free trial →

Countries with the most funded Series A Biotechnology startups

Where funded Series A Biotechnology startups are headquartered, by the country on the company record.

Where are funded Series A Biotechnology startups located?

Where funded Series A Biotechnology startups are based, by the city on the company record.

Top investors in Series A Biotechnology startups

The investors named most often across funded Series A Biotechnology startups.

Investor
Companies backed
Eli Lilly
4
RA Capital Management
3
Gaingels
2
Matrix Partners China
2
Michael J. Fox Foundation
2
National Science Foundation
2

Counts companies in this segment that name the firm as a backer. Investor names entered the pipeline in July 2026, so they cover the companies funded since.

About the FundedIQ Series A Biotechnology startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 571 funded Series A Biotechnology startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (13 of 202 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Series A Biotechnology startups is dated Sep 2026.

The table above shows the 100 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Series A Biotechnology startups are there?

FundedIQ tracks 571 funded Series A Biotechnology startups. This page lists the 100 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Series A Biotechnology startups raised?

Series A Biotechnology startups tracked by FundedIQ have raised $8.0B in disclosed capital across 202 funding rounds over the last 24 months, including 116 rounds in the last 12 months. 189 of those 202 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Series A Biotechnology startups?

United States leads with 338 companies, ahead of United Kingdom (52), France (30) and Germany (16).

Which cities have the most funded Series A Biotechnology startups?

Cambridge leads with 37 companies, then San Diego (29), San Francisco (28) and Boston (23).

Which investors back the most Series A Biotechnology startups?

Eli Lilly, RA Capital Management, Gaingels, Matrix Partners China and Michael J. Fox Foundation appear most often across funded Series A Biotechnology startups in the FundedIQ dataset. The count is the number of tracked companies naming each firm as a backer, so it reflects the companies on record rather than every deal a firm has ever done.

What is a typical funding round size for Series A Biotechnology startups?

The median disclosed round over the last 24 months is $20M, and the middle half of rounds fall between $11M and $50M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

How often is the Series A Biotechnology startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Series A Biotechnology startups is dated Sep 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.